TATAR, E. Et Al. 2016. Design, Synthesis, and Molecular Docking Studies of a Conjugated-Thiadiazole Thiourea Scaffold as Antituberculosis Agents. BIOLOGICAL & PHARMACEUTICAL BULLETIN , vol.39, no.4 , 502-515.

TATAR, E., KARAKUŞ, S., KÜÇÜKGÜZEL, Ş. G., Okullu, S. O., Unubol, N., Kocagoz, T., ... De Clercq, E.(2016). Design, Synthesis, and Molecular Docking Studies of a Conjugated-Thiadiazole Thiourea Scaffold as Antituberculosis Agents. BIOLOGICAL & PHARMACEUTICAL BULLETIN , vol.39, no.4, 502-515.

TATAR, ESRA Et Al. "Design, Synthesis, and Molecular Docking Studies of a Conjugated-Thiadiazole Thiourea Scaffold as Antituberculosis Agents," BIOLOGICAL & PHARMACEUTICAL BULLETIN , vol.39, no.4, 502-515, 2016

TATAR, ESRA Et Al. "Design, Synthesis, and Molecular Docking Studies of a Conjugated-Thiadiazole Thiourea Scaffold as Antituberculosis Agents." BIOLOGICAL & PHARMACEUTICAL BULLETIN , vol.39, no.4, pp.502-515, 2016

TATAR, E. Et Al. (2016) . "Design, Synthesis, and Molecular Docking Studies of a Conjugated-Thiadiazole Thiourea Scaffold as Antituberculosis Agents." BIOLOGICAL & PHARMACEUTICAL BULLETIN , vol.39, no.4, pp.502-515.

@article{article, author={ESRA TATAR Et Al. }, title={Design, Synthesis, and Molecular Docking Studies of a Conjugated-Thiadiazole Thiourea Scaffold as Antituberculosis Agents}, journal={BIOLOGICAL & PHARMACEUTICAL BULLETIN}, year=2016, pages={502-515} }